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Background: Patients with asthma have intermittent or persistent airflow obstruc-
tion, most often manifested spirometrically by reduced forced expiratory volume in
1 s (FEV1) and FEV1/vital capacity (VC) ratio. In some patients, the VC may be
reduced by air trapping, with an increase in functional residual capacity (FRC) and
residual volume (RV) (pseudorestriction). We have reported 12 asthmatic patients
with reduced VC and no increase in RV, i.e., a true restrictive impairment [Gill et al.
True restrictive impairment in bronchial asthma. Am J Respir Crit Care Med
1999:159:A652].
Objectives: To confirm previous observations of true restrictive impairment (not
attributable to air trapping) in patients with asthma, and to estimate its frequency
in an asthmatic population.
Methods: Review of pulmonary function tests and clinical records of all post-
pubertal patients diagnosed as asthma between January 2000 and September 2003 in
a 184 bed inner city teaching hospital in Jamaica, Queens, New York. The clinical
diagnosis of asthma was accepted when one or more of the following pulmonary
function criteria were met: Positive bronchodilator response (BD), positive
methacholine, repeated variability in spirometric values. Restriction was defined
as decrease in total lung capacity (TLC) or decrease in VC with no increase in
functional residual capacity (FRC) plus normal or high FEV1/FVC ratio. Patients with
any clinical finding consistent with restriction, including a decreased diffusing
capacity (DL) or obesity (BMI 430) were excluded.
Results: A total of 100 of 413 (24%) patients with asthma had restriction; 21 of these
met all exclusions (including DL and BMI) and 11 (of 46) patients with an increased
BMI and normal DL normalized their FVC on BD therapy, demonstrating that their pre-
BD restrictive impairment could not be attributed to obesity. Plethysmographic FRC
was measured in 81 of the 100 patients with restriction and was increased in only
seven.Elsevier Ltd. All rights reserved.
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(8%), consistent with previous observations in asthma and reactive airways
dysfunction syndrome. This finding is not widely recognized and should not preclude
the diagnosis of asthma, BD testing or appropriate therapy for asthma.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Asthma is a disorder characterized by increased
reactivity of the airways. Patients with asthma
have recurrent or persistent airflow obstruction,
which is reversible either spontaneously or with
appropriate therapy. An obstructive pattern is most
often present, recognized by reduced forced
expiratory volume in 1 s (FEV1), and FEV1 to forced
vital capacity (FEV1/FVC) or FEV1/vital capacity
(VC) ratio. Patients may have normal spirometry
between attacks. In some patients, the FVC may be
reduced due to air trapping, resulting in pseudo-
restriction on spirometry in the presence of
increased or normal total lung capacity (TLC),
increased functional residual capacity (FRC) and
increased residual volume (RV).
Several years ago, we reported on 12 asthmatics,
observed in a 2 years interval at a medium-sized
inner city teaching hospital, whose impairment on
pulmonary function testing was restrictive1; those
with any other reason for restriction, including
many who were obese, were excluded. The
diagnosis of asthma in these patients was often
called into question because of the report of
restrictive impairment and appropriate therapy
cancelled or delayed. The nature of this series did
not permit us to estimate the frequency of this
finding in the asthmatic population. We therefore
undertook a prospective review of pulmonary
function in all asthmatic adults during a subsequent
45-month interval, to confirm the observation of
restrictive impairment, to estimate its frequency
and to consider its mechanisms.Methods
Study design
We reviewed the pulmonary function tests (PFTs)
and clinical and demographic features of all post-
pubertal patients diagnosed as asthma between
January 2000 and September 2003 at the St.
Vincent Catholic Medical Center 184 bed Mary
Immaculate Hospital (MIH) division, Jamaica,
Queens, New York.Methods and definitions
The PFTs were performed according to American
Thoracic Society (ATS) specifications2,3 using Sen-
somedics Vmax 22 for spirometry and diffusing
capacity for carbon monoxide (DLCO) and model V
for plethysmographic FRC; FRC was measured in all
patients who could enter and tolerate the body
box; fewer than 20% were unable to do so for
orthopedic or psychologic reasons.
Forced exhalation time (FET) 100% X6 s or an
expiratory plateau was required of all spirometric
efforts accepted. Consistent with practice in the
United States and with the predicted values, forced
VC (FVC) was reported, although a separately
performed slow VC was used to calculate lung
volumes if it was larger than the FVC. Reference
values for spirometric4 and for static lung volumes5
were race adjusted for people of African origin2 and
those for DLCO6 were adjusted for smoking. The
lower 95% confidence interval was used to define
abnormality.
The diagnosis of asthma was accepted when the
following criteria were met:1. Physician diagnosis of asthma with intermittent
or persistent symptoms of shortness of breath,
wheezing and/or chest tightness.2. Confirmation by one of the following pulmonary
functional findings:
(a) Repeated variability in well-performed
spirometic values (increase in FEV1 or FVC).
(b) Positive bronchodilator (BD) responses (in-
crease in FEV1 or FVCX12% and 200mL from
baseline).
(c) Positive methacholine challenge (20% fall in
FEV1 at a dose p8 mg/mL).Restriction was defined as all of the following:1. Decrease in TLC or decrease in VC with no
increase in FRC. FRC was preferred to RV
because it is directly measured, and because of
the difficulty in measuring ERV especially in
obese patients.2. Normal or high FEV1/FVC ratio.
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diagnosis, congestive heart failure, radiographic
findings of interstitial lung disease (ILD), neuro-
muscular disorder or skeletal deformity were
excluded. Those with decreased DL and/or
BMI430 were placed in separate categories.Results
As seen in Table 1, of 413 patients with asthma, 107
(26%) had spirometric results within the normal
range, 180 (44%) were obstructed (decreased FEV1,
decreased FEV1/FVC, normal FVC) and an addi-
tional 26 (6%) showed spirometric mixed obstruc-
tive-restrictive impairment (decreased FEV1,
decreased FEV1/FVC with decreased FVC). Of the
100 asthmatic patients (24% of the total) with
spirometric restriction alone, plethysmographic
FRC was measured in 81 and was increased in only
seven. That FRC was not increased ruled out
‘‘pseudorestriction’’ secondary to air trapping. Of
these 100 patients with restriction, 63 had a BMI
430 (including 17 who also had a decreased DL)
and 16 had a decreased DL with a normal BMI.
There were 21 patients with restriction who had
both DL and BMI within the normal range.
Of the 46 patients with an increased BMI and
normal DL, 11 normalized their FVC post-BD or
within 4 weeks on treatment with no decrease inTable 1 Distribution of pulmonary function impairments
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21 (5%) 46 (10%)
k
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11 (3%)BMI. These 11 were added to the 21 with normal
BMI and DL since their initial restrictive impairment
could not be attributed to obesity.
True restrictive impairment was thus noted in at
least 32 of 413 asthmatics (8%). All 32 had normal
DL and of the 25 measured, 22 (88%) had normal or
decreased plethysmographic FRC. It is likely that
restriction was similarly attributable to asthma in
some of the 32 patients who had restriction and
decreased DL with no clinical or radiographic
evidence of ILD.
Age range of the 32 asthmatics with restrictive
impairment and no other explanation was 21–64; 24
(75%) were female, 18 (56%) were never-smokers, 3
(9%) former smokers; and 11 (34%) current smokers.
By ethnicity, 10 were Black, 8 Asian, 7 White, 6
Hispanic and one Amerindian.Discussion
The findings in these 32 asthmatic patients with
restriction mirror the 12 previously reported from
this hospital1 after the same process of exclusion in
both series. We rigidly ruled out other conditions
which could contribute to restrictive impairment. It
is likely that in certain asthmatic patients with
restrictive impairment who were excluded, their
restrictive impairment was similarly caused or





17 (5%) 16 (4%)
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patients by Colp and Williams,7 and attributed to
reversible closure of the airways. Hudgel and co-
workers8 reported a young woman with sponta-
neous and exercise-induced dyspnea. During a
typical episode, lung volumes decreased markedly
(TLC from 5.3 to 2.6 L, VC from 3.8 to 1.2 L), and
FEV1 fell from 3.0 to 1.0 L while FEV1/FVC ratio
increased (from 0.78 to 0.85) and specific airways
conductance and flow rates measured at absolute
lung volume increased. Static compliance de-
creased and elastic recoil increased. The authors
attributed these changes to muscular contraction
of small airways. Dawson cites closure of the
airways in young patients with seemingly mild
bronchospasm; FVC decreases and obstruction is
not detected because flow may be preserved in
other airways.9
One of the present authors (A.M.) reported
restrictive impairment in 21 patients with asthma
over a 4-year period in a part-time pulmonary
practice10; patients with other causes for restric-
tion were excluded, as in the present study. Full
lung volumes were generally not available to rule
out pseudorestriction.
True restrictive impairment with decreased FRC
and TLC and positive BD response has been described
in reactive airways dysfunction syndrome,11 most
recently as a result of exposure at Ground Zero
following the terrorist attack on the World Trade
Center. Of 599 non-smokers, 21% showed restriction
on spirometry. Unfortunately, lung volumes were not
measured.12 All exposure categories sustained
equivalent reductions in mean FVC and FEV1 with
little change in FEV1/FVC ratio.
13
One third of the patients (33 of 100) with
restrictive impairment had a decreased DL with
no clinical or radiographic evidence of pulmonary
interstitial or vascular disease. We have noted a
decreased DL in other patients with asthma and are
preparing a report on this finding.
An unpublished survey of the asthma population
of our hospital (n ¼ 238) undertaken during the
time of the earlier series showed 68% were females
and 39% obese; 13% of the males and 51% of the
females were obese. Pertinent to the present
report, 33% of the obese patients showed restric-
tive impairment on spirometry, as did 15% of the
non-obese. Unlike the present report, other possi-
ble causes for restriction were not systematically
excluded. The patients with restrictive impairment
in the present series reflect the gender and ethnic
distributions of our asthma population but are even
more likely to be obese (65%).
The high prevalence of obesity in asthma has
been the subject of extensive investigation14,15 andreview.16,17 In a 2000 Centers for Disease Control
and Prevention survey of almost 200,000 adults in
all 50 states, odds ratios for both lifetime and
current asthma were increased in the obese (1.54
and 1.65, respectively), more so in women.18Conclusion
True restrictive impairment was noted in at least 32
of 413 asthmatics (8%), consistent with previous
observations in asthma and reactive airways dys-
function syndrome. This finding is not widely
recognized and should not preclude the diagnosis
of asthma, BD testing or appropriate therapy for
asthma.Acknowledgment
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